CD8A and acute myeloid leukemia: In particular, in AML patients treated with HMA and VEN a depletion of total T, B and NK cells and an increase of the CD4+ and CD8+ T-cell frequencies with an effector memory phenotype at the expense of naïve T cells have been observed (29).